Evidence map›Paper›PMID 34417223›Full record

ArticleArchives of disease in childhood. Fetal and neonatal edition2022

SARS-CoV-2 RNA and antibody detection in breast milk from a prospective multicentre study in Spain.

Christine Bäuerl, Walter Randazzo, Gloria Sánchez, Marta Selma-Royo, Elia García Verdevio, Laura Martínez, Anna Parra-Llorca, Carles Lerin, Victoria Fumadó, Francesca Crovetto and 8 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Archives of disease in childhood. Fetal and neonatal edition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
12.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 87 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. A large series of molecular and serological specimens to evaluate mother-to-child SARS-CoV-2 transmission: a prospective study from the Italian Obstetric Surveillance System.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2023
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Observational
  19. Article
  20. [Main changes in the «COVID-19 in paediatrics» clinical practice guideline].Anales de pediatria (Barcelona, Spain : 2003) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 1 country.

Christine BäuerlDepartment of Biotechnology, Institute of Agrochemistry and Food Technology-National Research Council (IATA-CSIC), Paterna, Valencia, Spain.
Walter RandazzoDepartment of Preservation and Food Safety Technologies, Institute of Agrochemistry and Food Technology-National Research Council (IATA-CSIC), Paterna, Valencia, Spain.
Gloria SánchezDepartment of Preservation and Food Safety Technologies, Institute of Agrochemistry and Food Technology-National Research Council (IATA-CSIC), Paterna, Valencia, Spain.ORCID http://orcid.org/0000-0001-7022-661X
Marta Selma-RoyoDepartment of Biotechnology, Institute of Agrochemistry and Food Technology-National Research Council (IATA-CSIC), Paterna, Valencia, Spain.
Elia García VerdevioDepartment of Gynecology and Obstetrics, Hospital Universitario Dr Peset, Valencia, Spain.
Laura MartínezDepartment of Paediatrics, Hospital Clínico Universitario de Valencia, Nutrition Research Group of INCLIVA, Valencia, Spain.
Anna Parra-LlorcaHealth Research Institute La Fe, Neonatal Research Group and University and Polytechnic Hospital La Fe, Division of Neonatology, Valencia, Spain.
Carles LerinDepartment of Endocrinology, Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Déu, Barcelona, Spain.
Victoria FumadóDepartment of Infectious and Imported Diseases, Paediatric Unit, Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Déu, Barcelona, Spain.
Francesca CrovettoBCNatal - Barcelona Center for Maternal-Fetal and Neonatal Medicine, Hospital Sant Joan de Déu and Hospital Clínic, University of Barcelona, CIBERER, Barcelona, Spain.
Fatima CrispiBCNatal - Barcelona Center for Maternal-Fetal and Neonatal Medicine, Hospital Sant Joan de Déu and Hospital Clínic, University of Barcelona, CIBERER, Barcelona, Spain.
Francisco J Pérez-CanoDepartment of Biochemistry and Physiology, Faculty of Pharmacy and Food Science, University of Barcelona, Barcelona, Spain.
Gerardo RodríguezUniversity of Zaragoza, Hospital Clínico Universitario Lozano Blesa, Zaragoza. Instituto de Investigación Sanitaria Aragón (IIS Aragón), Red de Salud Materno Infantil y del Desarrollo (SAMID), Zaragoza, Spain.
Gemma Ruiz-RedondoDepartment of Gynecology and Obstetrics, University Hospital Clinic "San Cecilio" - Health Sciences Technological Park (PTS), Granada, Spain.
Cristina CampoyDepartment of Paediatrics, University of Granada, Granada, Spain.
Cecilia Martínez-CostaDepartment of Paediatrics, Hospital Clínico Universitario de Valencia, Nutrition Research Group of INCLIVA, Valencia, Spain.ORCID http://orcid.org/0000-0003-1347-7521
Maria Carmen ColladoDepartment of Biotechnology, Institute of Agrochemistry and Food Technology-National Research Council (IATA-CSIC), Paterna, Valencia, Spain mcolam@iata.csic.es.ORCID http://orcid.org/0000-0002-6204-4864
MilkCORONA study team
Instituto de Agroquímica y Tecnología de Alimentos · ESHospital Sant Joan de Déu Barcelona · ESHospital Clínico Universitario de Valencia · ESHospital Universitario Doctor Peset · ESInstituto de Investigación Biosanitaria de Granada · ESUniversidad de Granada · ESUniversidad de Zaragoza · ESUniversitat de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo develop and validate a specific protocol for SARS-CoV-2 detection in breast milk matrix and to determine the impact of maternal SARS-CoV-2 infection on the presence, concentration and persistence of specific SARS-CoV-2 antibodies. DESIGN AND PATIENTS: This is a prospective, multicentre longitudinal study (April-December 2020) in 60 mothers with SARS-CoV-2 infection and/or who have recovered from COVID-19. A control group of 13 women before the pandemic were also included.

settingSeven health centres from different provinces in Spain.

main outcome measuresPresence of SARS-CoV-2 RNA in breast milk, targeting the N1 region of the nucleocapsid gene and the envelope (E) gene; presence and levels of SARS-CoV-2-specific immunoglobulins (Igs)-IgA, IgG and IgM-in breast milk samples from patients with COVID-19.

resultsAll breast milk samples showed negative results for presence of SARS-CoV-2 RNA. We observed high intraindividual and interindividual variability in the antibody response to the receptor-binding domain of the SARS-CoV-2 spike protein for each of the three isotypes IgA, IgM and IgG. Main Protease (MPro) domain antibodies were also detected in milk. 82.9% (58 of 70) of milk samples were positive for at least one of the three antibody isotypes, with 52.9% of these positive for all three Igs. Positivity rate for IgA was relatively stable over time (65.2%-87.5%), whereas it raised continuously for IgG (from 47.8% for the first 10 days to 87.5% from day 41 up to day 206 post-PCR confirmation).

conclusionsOur study confirms the safety of breast feeding and highlights the relevance of virus-specific SARS-CoV-2 antibody transfer. This study provides crucial data to support official breastfeeding recommendations based on scientific evidence.

Indexed as

AdultAntibodies, ViralCoronavirus Envelope ProteinsCoronavirus Nucleocapsid ProteinsCOVID-19FemaleHumansImmunoglobulinsLongitudinal StudiesMilk, HumanPhosphoproteinsProspective StudiesRNA, ViralSARS-CoV-2SpainAntibodies, ViralCoronavirus Envelope ProteinsCoronavirus Nucleocapsid Proteinsenvelope protein, SARS-CoV-2Immunoglobulinsnucleocapsid phosphoprotein, SARS-CoV-2PhosphoproteinsRNA, ViralCOVID-19global healthmicrobiologyneonatology

Identifiers

PMID34417223
PMCPMC8384494
OpenAlexW3196095361

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.